Axonics, Inc.

NasdaqGS:AXNX Stock Report

Market Cap: US$3.6b

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Axonics Future Growth

Future criteria checks 4/6

Axonics is forecast to grow earnings and revenue by 55.1% and 16.5% per annum respectively. EPS is expected to grow by 55.6% per annum. Return on equity is forecast to be 5.7% in 3 years.

Key information

55.1%

Earnings growth rate

55.6%

EPS growth rate

Medical Equipment earnings growth17.0%
Revenue growth rate16.5%
Future return on equity5.7%
Analyst coverage

Good

Last updated12 Nov 2024

Recent future growth updates

Recent updates

Axonics' Market Growth Strengthens Boston Scientific's Future

Nov 05

A Look At The Fair Value Of Axonics, Inc. (NASDAQ:AXNX)

Jul 14
A Look At The Fair Value Of Axonics, Inc. (NASDAQ:AXNX)

Axonics, Inc.'s (NASDAQ:AXNX) Earnings Haven't Escaped The Attention Of Investors

Jun 20
Axonics, Inc.'s (NASDAQ:AXNX) Earnings Haven't Escaped The Attention Of Investors

Is Axonics, Inc. (NASDAQ:AXNX) Trading At A 21% Discount?

Mar 27
Is Axonics, Inc. (NASDAQ:AXNX) Trading At A 21% Discount?

Here's Why We're Not At All Concerned With Axonics' (NASDAQ:AXNX) Cash Burn Situation

Feb 28
Here's Why We're Not At All Concerned With Axonics' (NASDAQ:AXNX) Cash Burn Situation

Is Axonics, Inc. (NASDAQ:AXNX) Trading At A 32% Discount?

Nov 28
Is Axonics, Inc. (NASDAQ:AXNX) Trading At A 32% Discount?

Axonics stock falls 5.6% after Needham downgrades rating

Oct 10

Axonics Stock Is A Buy Amid Current Capex Cycle

Sep 07

Axonics prices stock offering of 1.75M shares

Aug 03

Companies Like Axonics (NASDAQ:AXNX) Can Afford To Invest In Growth

Aug 02
Companies Like Axonics (NASDAQ:AXNX) Can Afford To Invest In Growth

Axonics: A Strong Medical Device Play With Significant Revenue Growth Opportunities

May 30

Axonics (NASDAQ:AXNX) Is In A Strong Position To Grow Its Business

Apr 19
Axonics (NASDAQ:AXNX) Is In A Strong Position To Grow Its Business

Earnings and Revenue Growth Forecasts

NasdaqGS:AXNX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202663574N/AN/A8
12/31/20255404765N/A10
12/31/2024454-231N/A6
9/30/2024432-6514N/A
6/30/2024409-21926N/A
3/31/2024387-16-16-10N/A
12/31/2023366-6-6-2N/A
9/30/2023343-12-12N/A
6/30/2023320-32-9-7N/A
3/31/2023296-46912N/A
12/31/2022274-6013N/A
9/30/2022241-76-16-13N/A
6/30/2022217-77-22-20N/A
3/31/2022194-80-33-31N/A
12/31/2021180-80-50-47N/A
9/30/2021162-76-71-69N/A
6/30/2021150-68-87-85N/A
3/31/2021120-63-88-86N/A
12/31/2020112-55-87-84N/A
9/30/202087-66-86-84N/A
6/30/202053-82-90-88N/A
3/31/202039-81-95-94N/A
12/31/201914-80-85-83N/A
9/30/20194-67-66-65N/A
6/30/20193-49-50-49N/A
3/31/20192-39-39-38N/A
12/31/20181-32-33-31N/A
9/30/20180-28-29-27N/A
6/30/20180-25N/A-24N/A
3/31/20180-20N/A-21N/A
12/31/20170-18N/A-18N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: AXNX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: AXNX is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: AXNX is expected to become profitable in the next 3 years.

Revenue vs Market: AXNX's revenue (16.5% per year) is forecast to grow faster than the US market (9% per year).

High Growth Revenue: AXNX's revenue (16.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: AXNX's Return on Equity is forecast to be low in 3 years time (5.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/11/14 10:12
End of Day Share Price 2024/11/14 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Axonics, Inc. is covered by 9 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Travis SteedBarclays
Travis SteedBofA Global Research
Christopher PasqualeGuggenheim Securities, LLC